Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹5,967 Cr₹5,819 Cr₹4,546 Cr₹4,689 Cr₹4,201 Cr

What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹5,967 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹5,967 Cr
Mar2024₹5,819 Cr
Mar2023₹4,546 Cr
Mar2022₹4,689 Cr
Mar2021₹4,201 Cr

How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2025 ₹5,967 Cr
2.55
Mar2024 ₹5,819 Cr
27.99
Mar2023 ₹4,546 Cr
-3.05
Mar2022 ₹4,689 Cr
11.63
Mar2021 ₹4,201 Cr -

Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,256.2 Cr -1.6% -5.3% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 7.1% -1.5% -6.2% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 2.8% -2.8% 6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 3.1% 4.2% 18.8% Stock Analytics
CIPLA ₹107,075.0 Cr 0.2% -12.5% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 2.2% -1.6% 0% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.6%

-5.3%

31.8%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses